Bromide

Bromide

SCHEMBL7424764

Br.Br.S=C(NCCCN(Cc1ccc(Br)cc1)c1ccccn1)NCCCn1ccnc1

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 11/20 0.98
SSTR2 P30874 8/20 0.98
QPCT Q16769 5/20 0.53
GBA1 P04062 4/20 0.48
RAD52 P43351 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7421851 0.99 SSTR4 (1.00) SSTR4SSTR2QPCTGBA1RAD52
SCHEMBL7421605 0.96 SSTR4 (1.00) SSTR4SSTR2QPCTGBA1RAD52
SCHEMBL7428204 0.90 SSTR4 (0.83) SSTR4SSTR2QPCT
SCHEMBL7427056 0.83 SSTR4 (1.00) SSTR4SSTR2QPCTGBA1
SCHEMBL7422102 0.82 SSTR4 (0.76) SSTR4SSTR2GBA1RAD52
SCHEMBL7421076 0.80 SSTR4 (1.00) SSTR4SSTR2GBA1
SCHEMBL7429342 0.80 SSTR4 (0.68) SSTR4SSTR2GBA1RAD52
Dimethylamine SCHEMBL7422105 0.80 SSTR4 (0.74) SSTR4SSTR2GBA1RAD52
SCHEMBL7419280 0.78 SSTR4 (1.00) SSTR4SSTR2GBA1
SCHEMBL7421016 0.78 SSTR4 (0.71) SSTR4SSTR2GBA1RAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6159941-A Use of somatostatin agonists and antagonists for treating diseases related to the eye NOVO NORDISK A/S (DK) 2000-12-12 US disclosed
US-6127343-A SELECTIVE, COMPETITIVE SOMATOSTATIN RECEPTOR LIGANDS OF NONPEPTIDE ORIGIN, FOR MEDIATING THE BIOLOGICAL EFFECT OF SOMATOSTATIN AGONISTS OR ANTAGONIST NOVO NORDISK A/S (DK) 2000-10-03 US disclosed
EP-1019050-A1 USE OF SOMATOSTATIN AGONISTS AND ANTAGONISTS FOR TREATING DISEASES RELATED TO THE EYE NOVO NORDISK A/S (DK) 2000-07-19 EP disclosed
EP-0912551-A1 SOMATOSTATIN AGONISTS AND ANTAGONISTS NOVO NORDISK A/S (DK) 1999-05-06 EP disclosed
WO-1998058646-A1 USE OF SOMATOSTATIN AGONISTS AND ANTAGONISTS FOR TREATING DISEASES RELATED TO THE EYE NOVO NORDISK A/S (DK) 1998-12-30 WO disclosed
WO-1997043278-A1 SOMATOSTATIN AGONISTS AND ANTAGONISTS NOVO NORDISK A/S (DK) 1997-11-20 WO disclosed